hymecromone

DRUG3 trials

Sponsors

Paul Bollyky, Aparna Goel, National Institute of Environmental Health Sciences (NIEHS)

Conditions

HealthyIdiopathic Pulmonary FibrosisInterstitial Lung DiseaseLung Diseases, InterstitialPrimary Sclerosing CholangitisRespiratory Disease

Phase 1

A Study of Oral Hymecromone and Hyaluronan Synthesis

CompletedNCT02780752

Paul BollykyHealthy, Respiratory Disease

Start: 2020-12-01End: 2021-05-10Updated: 2021-06-16

Phase 2

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

RecruitingNCT05295680

Aparna GoelPrimary Sclerosing Cholangitis

Start: 2023-05-10End: 2027-12-31Target: 24Updated: 2025-06-13

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

RecruitingNCT06325696

National Institute of Environmental Health Sciences (NIEHS)Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, Interstitial

Start: 2025-05-05End: 2027-12-31Target: 37Updated: 2026-07-28

Related Papers

Oral hymecromone decreases hyaluronan in human study participants

Journal of Clinical Investigation2022-05-0130 citations